Files Suggest a Graft Case in China May Expand

Sunday, July 21, 2013 - 23:40 in Psychology & Sociology

Newly revealed documents suggest that GlaxoSmithKline will not be the only global drug company to come under scrutiny as China widens its investigation.

Read the whole article on NY Times Health

More from NY Times Health

Learn more about

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net